{
    "nctId": "NCT03844685",
    "briefTitle": "Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen",
    "officialTitle": "RED CLOVER EXTRACT (PROMENSIL) AND LIFESTYLE CHANGES TO CONTRAST MENOPAUSAL SYMPTOMS IN PREMENOPAUSAL WOMEN WITH HORMONE-SENSITIVE BREAST CANCER RECEIVING ADJUVANT ANTI-ESTROGEN THERAPY",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 88,
    "primaryOutcomeMeasure": "Menopause Rating Scale (MRS)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically confirmed operable ER-positive breast cancer\n* Can be ductal carcinoma in situ (DCIS)\n* Absence of locoregional relapse or distant metastasis\n* Normal ovarian function\n* Menopause Rating Score \\> or equal to 8\n* Signed informed consent to participate\n\nExclusion Criteria:\n\n* Menopause Rating Score \\<8\n* Menopausal at diagnosis or at surgery\n* Previous malignancies other than in situ cervical carcinoma or non-melanoma skin cancer\n* Breast cancer recurrence\n* Metastatic breast cancer\n* Non-epithelial breast cancer at histological examination\n* In situ lobular breast cancer\n* Participation in other randomized clinical trials that could interfere with current study\n* Living distant from center and unable to attend for check-ups and meetings.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}